Reductions in C-reactive protein in older adults with type 2 diabetes are related to improvements in body composition following a randomized controlled trial of resistance training

Journal of Cachexia, Sarcopenia and Muscle

Volumn 5, Issue 2, 2014, Pages 111-120

  Mavros, Yorgi ^a,l   Kay, Shelley ^a   Simpson, Kylie A ^a   Baker, Michael K ^a,b,c   Wang, Yi ^a,d   Zhao, Ren R ^a   Meiklejohn, Jacinda ^a   Climstein, Mike ^e   O'Sullivan, Anthony J ^f   de Vos, Nathan ^a,g   Baune, Bernhard T ^h   Blair, Steven N ⁱ   Simar, David ^f   Rooney, Kieron ^a   Singh, Nalin A ^a,g   Fiatarone Singh, Maria A ^a,c,j,k  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BOND UNIVERSITY   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g Balmain Hospital   (Australia)

^h UNIVERSITY OF ADELAIDE   (Australia)

ⁱ UNIVERSITY OF SOUTH CAROLINA   (United States)

^j Hebrew Senior Life   (United States)

^k TUFTS UNIVERSITY   (United States)

^l Tufts University ^*  (Australia)

more..

Author keywords

Adiposity; Body composition; Inflammation; PRT; Skeletal muscle

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FAT MASS; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROGRESSIVE RESISTANCE TRAINING; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SKELETAL MUSCLE;

EID: 84902539550     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-014-0134-1     Document Type: Article

References (35)

1. Festa A, D'Agostino Jr R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102: 42-7.
2. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25: 4-7.
3. Kengne AP, Batty GD, Hamer M, Stamatakis E, Czernichow S. Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25, 979 participants from four U. K. prospective cohort studies. Diabetes Care. 2012;35: 396-403.
4. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107: 363-9. doi: 10. 1161/01. cir. 0000053730. 47739. 3c.
5. Lapice E, Maione S, Patti L, Cipriano P, Rivellese AA, Riccardi G, et al. Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy nonobese people. Diabetes Care. 2009;32: 1734-6. doi: 10. 2337/dc09-0176.
6. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19: 972-8. doi: 10. 1161/01. atv. 19. 4. 972.
7. Schaap LA, Pluijm SMF, Deeg DJH, Visser M. Inflammatory markers and loss of muscle mass (Sarcopenia) and strength. Am J Med. 2006;119: 526. e9-e17.
8. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89: 465.
9. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol. 1986;60: 1327-32.
10. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23: 469-80. doi: 10. 1111/j. 1464-5491. 2006. 01858. x.
11. Martin Bland J, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327: 307-10.
12. Mavros Y, Kay S, Anderberg KA, Baker MK, Wang Y, Zhao R, et al. Changes in insulin resistance and HbA1c are related to exercise-mediated changes in body composition in older adults with Type 2 Diabetes: interim outcomes from the GREAT2DO Trial. Diabetes Care. 2013. doi: 10. 2337/dc12-2196.
13. de Salles BF, Simao R, Fleck SJ, Dias I, Kraemer-Aguiar LG, Bouskela E. Effects of resistance training on cytokines. Int J Sports Med. 2010;31: 441-50. doi: 10. 1055/s-0030-1251994.
14. Jorge MLMP, de Oliveira VN, Resende NM, Paraiso LF, Calixto A, Diniz ALD, et al. The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism. 2011;60: 1244-52.
15. Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P, et al. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis. 2010;20: 608-17.
16. Boulé N, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001;286: 1218-27. doi: 10. 1001/jama. 286. 10. 1218.
17. You T, Ryan AS, Nicklas BJ. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab. 2004;89: 5517-22. doi: 10. 1210/jc. 2004-0480.
18. Brochu M, Mathieu ME, Karelis AD, Doucet É, Lavoie ME, Garrel D, et al. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study. Obesity. 2008;16: 1085-93.
19. Brooks N, Layne JE, Gordon PL, Roubenoff R, Nelson ME, Castaneda-Sceppa C. Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes. Int J Med Sci. 2007;4: 19-27.
20. Bataille RÉG, Klein B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum. 2005;35: 982-3.
21. Calabro P, Chang DW, Willerson JT, Yeh ETH. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol. 2005;46: 1112-3.
22. Anty R, Bekri S, Luciani N, Saint-Paul MC, Dahman M, Iannelli A, et al. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Am J Gastroenterol. 2006;101: 1824-33.
23. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107: 671-4. doi: 10. 1161/01. cir. 0000055188. 83694. b3.
24. Yasojima K, Schwab C, McGeer EG, McGeer PL. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol. 2001;158: 1039-51.
25. Jabs WJ, Theissing E, Nitschke M, Bechtel JFM, Duchrow M, Mohamed S, et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation. 2003;108: 1428-31.
26. Calabró P, Willerson JT, Yeh ETH. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003;108: 1930-2.
27. Jabs WJ, Lögering BA, Gerke P, Kreft B, Wolber EM, Klinger MHF, et al. The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol. 2002;33: 152-61.
28. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96: 939-49. doi: 10. 1161/01. res. 0000163635. 62927. 34.
29. Breen L, Phillips SM. Skeletal muscle protein metabolism in the elderly: interventions to counteract the 'anabolic resistance'of ageing. Nutr Metab. 2011;8: 68.
30. Pedersen B. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem. 2006;42: 105-17.
31. Pedersen BK. Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun. 2011;25: 811-6.
32. Morley JE, Chahla E, AlKaade S. Antiaging, longevity and calorie restriction. Curr Opin Clin Nutr Metab Care. 2010;13: 40-5. doi: 10. 1097/MCO. 0b013e3283331384.
33. Rieu I, Magne H, Savary-Auzeloux I, Averous J, Bos C, Peyron MA, et al. Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats. J Physiol. 2009;587: 5483-92. doi: 10. 1113/jphysiol. 2009. 178319.
34. Fetterman JW, Zdanowicz MM. Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health Syst Pharm. 2009;66: 1169-79. doi: 10. 2146/ajhp080411.
35. Smith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ, et al. Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and women. Clin Sci. 2011;121: 267-78.